When you eat, your body releases GLP-1, which then acts on the brain, pancreas, and stomach
External resources Physiology of the Weight Loss Plateau after GLP-1 Receptor Agonism - PMC Tolerance Does Not Develop Toward Liraglutide Glucose-Lowering Effect - JCEM For researchers serious about optimizing their GLP-1 protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
The following is a brief overview of clinical trial data available to date
GLP-1s delay gastric emptying, leading to bloating, fullness, and nausea
Since commercial patients tend to be younger and healthier than Medicare beneficiaries, early GLP-1 use is reinforcing its role as a reliable foundation for diabetes care and could be a contributing factor to rising rates of monotherapy
In this comprehensive guide, we will explore everything you need to know about timing your first GLP-1 dose, from practical considerations around your weekly schedule to understanding how your body might respond during the initial adjustment period
